glp-1 agonists and inflammation drugs calm beyond diabetes weight loss Frontiers | GLP-1 receptor agonists
Description
Pure Medical Spa
Administration of linagliptin (10 mg/kg/day), a DPP-4 inhibitor, to ApoE / mice, an animal model of atherosclerosis, decreased inflammatory molecule expression and macrophage infiltration in the atherosclerotic aorta [65]
Moreover, one phase 2 study conducted by Astrup et al
Beyond its metabolic effects, GLP-1 exerts anti-inflammatory effects via several molecular pathways
-Arrestins as Important Regulators of Glucose and Energy Homeostasis
